arylalkenes and aryl bromides with hydrosilanes by cooperative palladium/copper catalysis was developed, thus resulting in the highly regioselective formation of various 1,1‐diarylalkanes, including a biologically active molecule. Under the applied reaction conditions, high levels of functional‐group tolerance were observed, and the reductive cross‐coupling of internal alkynes with aryl bromides afforded
Ni‐catalyzed hydroarylation of styrenes and 1,3‐dienes with organoboron compounds has been developed. The reaction offers a highly selective approach to diarylalkanes and allylarenes under redox‐neutral conditions. In this hydroarylation reaction, a new strategy that uses the proton of methanol to generate the active catalyst species Ni−H was developed. The Ni‐catalyzed hydroarylation, combined with
The present invention provides a compound having antiviral effects, particularly having growth inhibitory activity on influenza viruses, a preferred example of the compound being a substituted 3 - hydroxy-4-pyridone derivative prodrug having cap-dependent endonuclease inhibitory activity.